Genes regulating capillary morphogenesis and apoptosis

调节毛细血管形态发生和细胞凋亡的基因

基本信息

  • 批准号:
    7915674
  • 负责人:
  • 金额:
    $ 37.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-03-15 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In this renewal proposal, we continue our work demonstrating the critical role of the Rho GTPase, Cdc42, in the molecular control of endothelial cell (EC) lumenogenesis in early blood vessel assembly during vasculogenesis. Our overall hypothesis is that Cdc42 represents a central signaling molecule in EC lumen formation and tube morphogenesis because of its key role in cell polarity pathways as well as coordinating cell signaling pathways controlling vesicular trafficking and fusion events involving intracellular vacuoles that are fundamental to this process. During this last funding period, we have made essential progress in demonstrating the function of Cdc42 in lumen formation as well as the identification of critical downstream Cdc42 effectors required for these events. Also, we have shown that intracellular vacuole formation and fusion are critical regulators of lumenogenesis both in vitro and in vivo during Zebrafish development (collaborative work with Dr. Brant Weinstein). We are able to label and visualize the intracellular vacuoles in vitro and in vivo using GFP-Cdc42 which further suggests a functional role for Cdc42 during these events. Also, we have developed essential experimental approaches such siRNA technology and its functional application in our morphogenic systems, real-time image analysis of EC lumenogenesis in 3D collagen matrices, proteomic capture techniques during tube morphogenesis to identify Cdc42-associated proteins which regulate lumen formation and identification of critical signal transduction cascades that control these events. We propose three specific aims which are; Specific Aim #1: To determine the molecular mechanisms by which the Cdc42 effectors, Pak2 and Pak4, control EC lumen and network formation in 3D collagen matrices. Specific Aim #2: To define how cell polarity signaling pathways involving Cdc42, Par3, Par6 and PKC zeta control the EC lumen formation mechanism in 3D collagen matrices. Specific Aim #3: To investigate the role of JamC and JamB in EC lumen formation and identify and characterize upstream Cdc42 GEFs which activate Cdc42 to control these events. PUBLIC HEALTH RELEVANCE: This work focuses on the ability of blood vessel lining cells to tube-like structures within three- dimensional environments such as collagen, which is a major structural component of tissue. These lining cells carry a group of proteins that control their ability to assemble into a cell-lined tube and which are required to assemble cellular networks of vessels to develop our blood vascular system. A basic understanding of the mechanisms underlying how blood vessels form is critical in efforts to stimulate or inhibit the process in the context of various human diseases such as cardiovascular disease or cancer.
描述(由申请人提供):在本更新提案中,我们继续我们的工作,证明Rho GTdR,Cdc 42在血管发生期间早期血管组装中内皮细胞(EC)管腔形成的分子控制中的关键作用。我们的总体假设是,Cdc 42代表了一个中央信号分子在EC管腔形成和管形态发生,因为它在细胞极性通路以及协调细胞信号通路控制囊泡贩运和融合事件,涉及细胞内空泡是这个过程的基础上的关键作用。在最近的资助期间,我们在证明Cdc 42在管腔形成中的功能以及确定这些事件所需的关键下游Cdc 42效应物方面取得了重要进展。此外,我们已经表明,细胞内空泡的形成和融合是斑马鱼发育过程中体外和体内管腔形成的关键调节因子(与Brant Weinstein博士合作)。我们能够使用GFP-Cdc 42在体外和体内标记和可视化细胞内空泡,这进一步表明Cdc 42在这些事件中的功能作用。此外,我们已经开发了必要的实验方法,如siRNA技术及其在我们的形态发生系统中的功能性应用,在3D胶原基质中EC管腔形成的实时图像分析,在管形态发生过程中的蛋白质组学捕获技术,以识别Cdc 42相关蛋白,其调节管腔形成并识别控制这些事件的关键信号转导级联。我们提出了三个具体目标,具体目标#1:确定Cdc 42效应子Pak 2和Pak 4控制EC管腔和3D胶原基质网络形成的分子机制。具体目标#2:目的:探讨Cdc 42、Par 3、Par 6和PKC zeta等细胞极性信号通路在三维胶原基质中调控EC管腔形成的机制。具体目标#3:研究JamC和JamB在EC管腔形成中的作用,并鉴定和表征激活Cdc 42以控制这些事件的上游Cdc 42 GEF。公共卫生关系:这项工作的重点是血管衬里细胞的能力,以管状结构的三维环境,如胶原蛋白,这是一个主要的组织结构组成部分。这些内衬细胞携带一组蛋白质,这些蛋白质控制它们组装成细胞内衬管的能力,并且需要组装血管的细胞网络以发育我们的血管系统。对血管形成机制的基本理解对于在各种人类疾病(如心血管疾病或癌症)的背景下刺激或抑制该过程至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George E Davis其他文献

Talin1 is required for cardiac Z-disk stabilization and endothelial integrity in zebrafish.
Talin1 是斑马鱼心脏 Z 盘稳定和内皮完整性所必需的。
  • DOI:
    10.1096/fj.15-273409
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Qing Wu;Jiaojiao Zhang;Wonshill Koh;Qingming Yu;Xiaojun Zhu;Adam Amsterdam;George E Davis;M Amin Arnaout;Jing-Wei Xiong
  • 通讯作者:
    Jing-Wei Xiong

George E Davis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George E Davis', 18)}}的其他基金

Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
  • 批准号:
    10192817
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
  • 批准号:
    10619624
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
  • 批准号:
    10408085
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
Novel growth factor and signaling requirements for human capillary tube assembly
人体毛细管组装的新型生长因子和信号传导要求
  • 批准号:
    9102169
  • 财政年份:
    2015
  • 资助金额:
    $ 37.38万
  • 项目类别:
Novel growth factor and signaling requirements for human capillary tube assembly
人体毛细管组装的新型生长因子和信号传导要求
  • 批准号:
    8942261
  • 财政年份:
    2015
  • 资助金额:
    $ 37.38万
  • 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
  • 批准号:
    8021934
  • 财政年份:
    2011
  • 资助金额:
    $ 37.38万
  • 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
  • 批准号:
    8207865
  • 财政年份:
    2011
  • 资助金额:
    $ 37.38万
  • 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
  • 批准号:
    8593308
  • 财政年份:
    2011
  • 资助金额:
    $ 37.38万
  • 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
  • 批准号:
    8402619
  • 财政年份:
    2011
  • 资助金额:
    $ 37.38万
  • 项目类别:
Molecular and Cellular Biology Core
分子和细胞生物学核心
  • 批准号:
    7918622
  • 财政年份:
    2010
  • 资助金额:
    $ 37.38万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 37.38万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 37.38万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 37.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了